Abstract
Osteoimmunology (OI) is a relatively new field in medicine, improving our understanding of the pathogenesis of the rheumatic diseases. OI focuses on the relationship and interaction between the immune and the musculoskeletal systems, observing these processes in three main aspects: regulating the bone resorption by the immune system, the impact of inflammation on the bone formation, the role of bone and bone marrow as a depot for immune cells. Changes in the bone architecture may be due to the activation of the immune system. Proinflammatory cytokines leading in the pathogenesis ofthe inflammatory joint disease are potent activators of nuclear factor-kB receptor activator (RANKL) expression and thus promote the osteoclast differentiation. This link explains why therapy whose target are the cytokines , especially TNF inhibition, is very effective in delaying structural damage in rheumatic diseases. Knowledge of these mechanisms would allow better use of medical therapies to reduce skeletal damage.
References
- Fuchs RK, Thompson WR, Warden SJ. Bone anatomy, physiology and adaptation to mechanical loading. In: Pawelec KM, Planell JA, editors. Bone Repair Biomaterials. 2nd ed. Cambridge, England: Woodhead Publishing Ltd; 2019. p. 15-52.
- Gorski J.P., Hankenson K.D. 2020 Principles of Bone Biology (2 Volume Set) [4th Edition], p. 359-378.
- Hochberg M.C., Silman A.J., Smolen J.S. et al. Rheumatology 2015, (1 Volume Set) [7th Edition], p.
- -50, 62-87
- Takayanagi H. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems, Nature Reviews Immunology volume 7, pages 292–304 (2007)
- Kong Y.Y., Yoshida H., Sarosi I. et al., OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis Nature volume 397, pages 315–323 (1999)
- Kojiro Sato 1, Ayako Suematsu, Kazuo Okamoto et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction, J exp Med. 2006 Nov 27;203(12):2673-82.
- Harre U., Georgess D. et al., Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin, J Clin Invest. 2012 May;122(5):1791-802.
- Van Staa TP, Geusens P. et al., Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis Arthritis Rheum. 2006 Oct;54(10):3104-12.
- Benjamin M., McGonagle D., The Anatomical Basis for Disease Localisation in Seronegative Spondyloarthropathy at Entheses and Related Sites, December 2001, Journal of Anatomy 199(Pt 5):503-26
- Lories RD, Derese I et al., Modulation of bone morphogenetic protein signaling inhibits the onset and progression of ankylosing enthesitis J Clin invest. 2005 Jun;115(6):1571-9.
- Méndez-Ferrer S., Michurina T.V., Ferraro F., Mesenchymal and haematopoietic stem cells form a unique bone marrow niche Nature volume 466, pages 829–834 (2010)
- Mansour A., Abou-Ezzi G, Sitnicka E., Osteoclasts promote the formation of hematopoietic stem cell niches in the bone marrow, J Exp Med. 2012 Mar 12; 209(3): 537–549.
- Fabienne Coury, Olivier Peyruchaud and Irma Machuca-Gayet, Osteoimmunology of Bone Loss in Inflammatory Rheumatic Diseases, Front Immunol. 2020; 11: 58
- Georg Schett, Osteoimmunology in rheumatic diseases, Arthritis Research & Therapy, volume 11, Article number: 210 (2009)
- Christian Guder, Sascha Gravius, Christof Burger, Dieter C. Wirtz and Frank A. Schildberg, Osteoimmunology: A Current Update of the Interplay Between Bone and the Immune System, Front Immunol., 2020 Jan 31;11:58
- Ikonomova K., Toncheva A., New directions in bone biology, Sofia, 2010
- Momcheva I., Kazmin I., Hristova Sv., Madjova V., Osteoarthritis and immunity ,Rheumatology , vol XXIX, 1/2021
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.